During the past decade, Oncological Specialist Practice conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Oncological Specialist Practice" are "Chronic Lymphocytic Leukemia" (2 trials). Many other conditions were trialed in "Oncological Specialist Practice" in a lesser frequency.

Most popular intervention types in "Oncological Specialist Practice" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Fludarabine" (2 trials) and "Chlorambucil" (1 trials). Other intervention names were less common.

The vast majority of trials in "Oncological Specialist Practice" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Oncological Specialist Practice". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Oncological Specialist Practice, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Oncological Specialist Practice, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".